Archives

by in
Entry Author Date Location
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal with Glaxo 02/25/10 San Diego
Alnylam Maps Out First Steps in ‘RNA Decade’ 01/11/10 Boston
Regulus Adds IP from Baltimore Lab 12/17/09 San Diego
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday 12/09/09 San Diego
San Diego Biotech Leaders on the Future of Stem Cells, MicroRNA, & Cancer Biology 12/01/09 San Diego
NanoString Forges Closer Ties With Broad Institute to See What Genetic Tool Can Really Do 11/18/09 Seattle
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target 11/11/09 Boston
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region 11/10/09 San Diego
Santaris Nabs Isis, Amgen Vets 10/28/09 San Diego
Yale startup 3PrimiR Raises $2.1M 09/16/09 Boston
MicroRNA Drug Developer Santaris Establishes Toehold in San Diego With Isis Veteran 09/16/09 San Diego
$50M for Helicon, Cytori Bulks Up, Avanir Awaits Trial Results, & More San Diego Life Sciences News 07/30/09 San Diego
Alnylam and Isis’ Offspring, Regulus, Keeps Pushing on Biology’s ‘Bleeding Edge’ 07/28/09 San Diego
Archemix Signs MicroRNA Deal 07/23/09 Boston
Regulus Hits GSK Milestone 05/14/09 San Diego
Leroy Hood, ISB Scientists Spot Genes For “Mad Cow” Disease; May Lead to Diagnostic Test 03/24/09 Seattle
Alnylam Looks to Spinoffs To Unleash RNAi Technologies for Stem Cells, Vaccines 02/18/09 Boston
Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis 01/21/09 San Diego
MicroRNA Leaps Ahead: Alnylam-Isis Venture, Regulus, Shows Its Drug Works in Animals With Heart Failure 11/30/08 San Diego
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments 10/24/08 San Diego
Dendreon Proceeds With Prostate Cancer Clinical Trials, AXI Gets Oil from Algae, PATH Prepares to Launch “Ultra Rice,” & More Deals News 08/18/08 Seattle
Accelerator Bankrolls New Company, Mirina, To Develop MicroRNA-Blocking Drugs 08/15/08 Seattle
Rocky Mountain High: Atlas Venture Is Banking on microRNA for Miragen 05/22/08 Boston
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million 04/17/08 Boston
Page 2 of 2 « previous page

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.